The Archaeological Survey of India (ASI) on Saturday examined the central hall of the Gyanvapi mosque on the second day of the scientific survey to determine if the 17th-century mosque was constructed over a pre-existing structure of a Hindu temple. Five members from the Muslim side were also present during the survey, after having stayed… Continue reading ASI conducts scientific survey of Gyanvapi for 2nd day, to continue on Sun
Tag: Sun
Wet spell to continue in Himachal till Aug 11; heavy rains forecast for Sun
Representative Image (Photo: ANI Twitter) The wet spell in Himachal Pradesh is likely to continue till August 11, the MeT office here said while issuing a yellow alert for heavy rains on Sunday. Light to heavy rains lashed parts of the hill state on Friday and Saturday, the weather department added. In… Continue reading Wet spell to continue in Himachal till Aug 11; heavy rains forecast for Sun
Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Sun Pharmaceutical Industries posted a near 2 per cent year-on-year (YoY) decline in profit after tax (PAT) for the first quarter of FY24 to Rs 2,022.5 crore due to a one-time exceptional expense. The firm’s total income grew by almost 13 per cent. The firm’s stock ended flat at Rs 1,140.85 on the… Continue reading Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Sun Pharma Q1 profit may be weighed by weak US specialty sales and Taro nos
Drugmaker Sun Pharmaceutical Industries (Sun Pharma) is expected to report a muted net profit for the June quarter (Q1FY24) when it announces its earnings on Thursday, August 3. The pressure on earnings is likely due to flat growth for the arm Taro Pharma, weak US generic sales as a result of product restrictions at… Continue reading Sun Pharma Q1 profit may be weighed by weak US specialty sales and Taro nos
Domestic drug makers Sun Pharma, Alembic recall drugs in US market
Domestic drug makers Sun Pharma and Alembic are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). As per the US health regulator’s latest Enforcement Report, the Mumbai-based drug major is recalling 12,336 bottles of Buprenorphine Sublingual tablets, used for treating opioid use… Continue reading Domestic drug makers Sun Pharma, Alembic recall drugs in US market